Innate Pharma S.A. (EPA:IPH)
France flag France · Delayed Price · Currency is EUR
2.200
+0.100 (4.76%)
Feb 21, 2025, 5:37 PM CET

Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €184.39 million as of February 21, 2025. Its market cap has increased by 1.37% in one year.

Market Cap
184.39M
Enterprise Value
128.09M
Revenue
33.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.20

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 184.39M, an increase of 23,177.52%. That is a compound annual growth rate of 34.65%.

History

DateMarket Cap% Change
Feb 21, 2025184.39M15.29%
Dec 31, 2024159.94M-24.29%
Dec 29, 2023211.24M-19.93%
Dec 30, 2022263.84M-24.98%
Dec 31, 2021351.67M28.64%
Dec 31, 2020273.37M-41.60%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition